​

Compass Therapeutics Ownership | Who Owns Compass Therapeutics?

OverviewForecastFinancialsChart

Compass Therapeutics Ownership Summary

Compass Therapeutics is owned by 78.27% institutional investors, 11.42% insiders, and 10.32% retail investors. Tang capital management is the largest institutional shareholder, holding 12.16% of CMPX shares. Biotech Growth Ord is the top mutual fund, with 2.58% of its assets in Compass Therapeutics shares.

CMPX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCompass Therapeutics78.27%11.42%10.32%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management16.81M12.16%$58.84M
Orbimed advisors15.22M11.01%$53.27M
Suvretta capital management14.10M10.20%$49.35M
Blackstone9.84M7.12%$34.44M
Vivo capital9.55M6.90%$33.41M
Enavate sciences gp7.79M5.63%$27.26M
Blackrock funding, inc. /de7.37M5.33%$25.80M
Vanguard group7.06M5.11%$24.72M
Blackrock6.61M4.84%$6.61M
Adage capital partners gp5.19M3.75%$18.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Enavate sciences gp7.79M8.32%$27.26M
Acuta capital partners840.09K3.04%$2.94M
Bioimpact capital5.08M2.91%$17.77M
Blue owl capital lp2.59M2.82%$9.07M
Vivo capital9.55M2.69%$33.41M
Birchview capital, lp872.94K2.31%$3.06M
Tang capital management16.81M2.27%$58.84M
Monashee investment management1.25M2.18%$4.38M
Silverarc capital management2.83M1.34%$9.92M
Suvretta capital management14.10M1.26%$49.35M

Top Buyers

HolderShares% AssetsChange
Suvretta capital management14.10M1.26%6.95M
Bvf inc/il4.75M0.67%4.75M
Vivo capital9.55M2.69%3.50M
Tang capital management16.81M2.27%3.32M
Rtw investments, lp2.50M0.11%2.50M

Top Sellers

HolderShares% AssetsChange
Opaleye management---3.17M
Cormorant asset management, lp---2.03M
Janus henderson group---1.84M
Caption management154.17K0.00%-571.34K
Baker bros. advisors lp---547.50K

New Positions

HolderShares% AssetsChangeValue
Bvf inc/il4.75M0.67%4.75M$16.63M
Rtw investments, lp2.50M0.11%2.50M$8.75M
Logos global management lp2.05M0.64%2.05M$7.17M
Sofinnova investments2.03M0.39%2.03M$7.10M
Acuta capital partners840.09K3.04%840.09K$2.94M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-16.00
Ifp advisors-16.00
True wealth design-20.00
Us bancorp \de\-65.00
Capital performance advisors llp-172.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025105-18.60%108,229,435-0.20%781.26%42-37.31%4348.28%
Mar 31, 202510-89.01%39,938,686-60.60%290.53%5-91.07%2-88.24%
Dec 31, 2024801.27%44,181,101-52.07%320.72%5230.00%13-31.58%
Sep 30, 202479-2.47%92,186,861-0.73%671.46%40-14.89%1911.76%
Jun 30, 2024813.85%92,861,661-1.80%671.23%4774.07%17-51.43%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Biotech Growth Ord3.57M2.58%-
Vanguard Total Stock Mkt Idx Inv2.56M1.86%-56.41K
Vanguard US Total Market Shares ETF2.19M1.58%-
iShares Russell 2000 ETF2.29M1.33%-
Vanguard Institutional Extnd Mkt Idx Tr1.06M0.77%-445.10K
JPMorgan Small Cap Value I1.29M0.75%-26.19K
Fidelity Small Cap Index919.63K0.67%-118.08K
Simplify Propel Opportunities ETF720.00K0.52%600.00K
Janus Henderson Hrzn Biotec E2 USD534.18K0.39%-1.42K
State St Russell Sm/Mid Cp® Indx NL Cl C524.30K0.38%-

Recent Insider Transactions

DateNameRoleActivityValue
May 27, 2025Schuetz Thomas J. CHIEF EXECUTIVE OFFICERBuy$21.10K
Apr 09, 2025GORDON CARL L Sell$5.68M
Apr 09, 2025ORBIMED ADVISORS LLC Sell$5.68M
Apr 07, 2025Anderman Jonathan Gen Counsel & Corporate SecBuy$30.80K
Apr 07, 2025Lerner Neil CHIEF ACCOUNTING OFFICERBuy$28.40K

Insider Transactions Trends

DateBuySell
2025 Q232
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q1--

CMPX Ownership FAQ

Who Owns Compass Therapeutics?

Compass Therapeutics shareholders are primarily institutional investors at 78.27%, followed by 11.42% insiders and 10.31% retail investors. The average institutional ownership in Compass Therapeutics's industry, Biotech Stocks , is 295.31%, which Compass Therapeutics falls below.

Who owns the most shares of Compass Therapeutics?

Compass Therapeutics’s largest shareholders are Tang capital management (16.81M shares, 12.16%), Orbimed advisors (15.22M shares, 11.01%), and Suvretta capital management (14.1M shares, 10.20%). Together, they hold 33.36% of Compass Therapeutics’s total shares outstanding.

Does Blackrock own Compass Therapeutics?

Yes, BlackRock owns 4.84% of Compass Therapeutics, totaling 6.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.61M$. In the last quarter, BlackRock increased its holdings by 581.17K shares, a 9.63% change.

Who is Compass Therapeutics’s biggest shareholder by percentage of total assets invested?

Enavate sciences gp is Compass Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.32% of its assets in 7.79M Compass Therapeutics shares, valued at 27.26M$.

Who is the top mutual fund holder of Compass Therapeutics shares?

Biotech Growth Ord is the top mutual fund holder of Compass Therapeutics shares, with 2.58% of its total shares outstanding invested in 3.57M Compass Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools